Literature DB >> 8832698

A facile method for the labeling of proteins with zirconium isotopes.

W E Meijs1, H J Haisma, R Van der Schors, R Wijbrandts, K Van den Oever, R P Klok, H M Pinedo, J D Herscheid.   

Abstract

To label proteins with positron emitters with a half-life in the order of days, a method has been developed to label proteins with zirconium (Zr)-isotopes. Therefore, the bifunctional chelating agent desferal (Df) was coupled to albumins via a thioether bond. Labeling of the premodified proteins was easily performed by addition of these proteins to freeze-dried Zr-oxalate. This labeling was efficient (> 90%) and accomplished in several minutes. The conjugates showed a high in vitro stability. Biodistribution studies were performed with 88Zr-citrate, 88Zr-Df, and 88Zr-labeled mouse serum albumin (88Zr-Df-MSA), modified with different amounts of chelating groups. Whereas Zr-citrate was found to accumulate in bone, Zr-Df was cleared very fast by glomerular filtration. The 88Zr-Df-MSA showed similar blood clearance as did 123I-labeled MSA. The biodistribution pattern of 88Zr-Df-MSA differed only from 123I-MSA in that a higher accumulation of Zr in liver, kidney, and spleen was found. The absence of large amounts of 88Zr in bone indicated that in vivo the conjugates are also reasonably stable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832698     DOI: 10.1016/0969-8051(96)00020-0

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  18 in total

Review 1.  PET tracers based on Zirconium-89.

Authors:  Yin Zhang; Hao Hong; Weibo Cai
Journal:  Curr Radiopharm       Date:  2011-04

2.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

Review 3.  Progress of Coordination and Utilization of Zirconium-89 for Positron Emission Tomography (PET) Studies.

Authors:  Minh Thanh La; Van Hieu Tran; Hee-Kwon Kim
Journal:  Nucl Med Mol Imaging       Date:  2019-01-29

Review 4.  PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.

Authors:  Melissa A Deri; Brian M Zeglis; Lynn C Francesconi; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2012-09-19       Impact factor: 2.408

Review 5.  The next generation of positron emission tomography radiopharmaceuticals in oncology.

Authors:  Samuel L Rice; Celeste A Roney; Pierre Daumar; Jason S Lewis
Journal:  Semin Nucl Med       Date:  2011-07       Impact factor: 4.446

6.  In vivo biodistribution and accumulation of 89Zr in mice.

Authors:  Diane S Abou; Thomas Ku; Peter M Smith-Jones
Journal:  Nucl Med Biol       Date:  2011-03-03       Impact factor: 2.408

Review 7.  89Zr radiochemistry for positron emission tomography.

Authors:  Gregory W Severin; Jonathan W Engle; Todd E Barnhart; R Jerry Nickles
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

8.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

9.  Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.

Authors:  Jason P Holland; Eloisi Caldas-Lopes; Vadim Divilov; Valerie A Longo; Tony Taldone; Danuta Zatorska; Gabriela Chiosis; Jason S Lewis
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

10.  Total-Body PET and Highly Stable Chelators Together Enable Meaningful 89Zr-Antibody PET Studies up to 30 Days After Injection.

Authors:  Eric Berg; Herman Gill; Jan Marik; Annie Ogasawara; Simon Williams; Guus van Dongen; Daniëlle Vugts; Simon R Cherry; Alice F Tarantal
Journal:  J Nucl Med       Date:  2019-09-27       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.